spacer
home > pmps > spring 2004 > editor's letter
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Editor's Letter

Spring came early this year for many regions of Europe and with it the first signs of a tentative recovery for the life science sector of industry. Then, just as the first green shoots pushed above ground or tree buds burst into blossom, a sharp frost or a howling gale reminded us that winter was not yet over. As I write from high up in the Swiss Alps, snow is falling heavily but the alpine plants appear well-adapted to these extremes of climate.

Media groups, including the publisher of PMPS, Samedan Ltd, are an early bellweather of the

sector's fortunes. Recalling that media organisations were the first to suffer at the signs of a long, hard winter as revenues took a nosedive, it's heartening to see an upturn in activity this year. The news from Bio/PharMOS, the early spring event in Monte Carlo which took place in March, was also very positive, with most exhibitors reporting a substantially higher level of enquiries and leads for contract manufacturing business, especially for secondary processing and packaging. The trend for outsourcing is, however, patchy and precarious. For example, the demand for production and development services in pharma, helped along to some extent by the booming generics market, has not been matched by the biotech sector.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Editor of PMPS, Patricia Lobo rounds up current issues impacting on development and manufacturing in biotech and pharma.
spacer
Patricia Lobo
spacer
spacer
spacer
Lucy Kearney
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

3rd African Regulatory Conference (ARC)

3-4 May 2012, Accra, Ghana

The African Regulatory Conference offers the opportunity for key stakeholders active on the continent, including representatives from Ministry of Health, local and multinational pharmaceutical companies, to meet to exchange views, discuss topics of interest and identify focus areas for ongoing efforts to increase patient access to new and improved medicines.
More info >>

 
News and Press Releases

Prism Ideas and dMetrics Launch Pioneering Service Analysing Patient–Reported Action, Behaviours and Outcomes with Social Media

Prism Ideas, the multi-national medical marketing and drug development consultants, today announced its collaboration with dMetrics, experts in identifying decisions made by millions of patients online, to launch a pioneering analysis service to evaluate patient healthcare outcomes reported within social media. Combining expertise in language analytics and healthcare, the two companies are interrogating social media to determine patient actions and insights, profiling patient needs, symptoms and response to treatment.
More info >>

 

 

Buy Atrovent Online no prescription Buy Symbicort Online no prescription Buy Flovent Online no prescription Buy Flonase Online no prescription Buy Rhinocort Online no prescription Buy Allegra Online no prescription Buy Advair Online no prescription Buy Combivent Online no prescription Buy Astelin Online no prescription Buy Spiriva Online no prescription Buy Ventolin Online no prescription
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement
.